The momentum behind IQCP is accelerating. Companies are launching education initiatives, new software programs, and there are webinars, workshops, and online tutorials. But does anyone really understand what an IQCP is yet? Does anyone know what the P stands for? Problem? Plan? Placebo?
We've talked about Westgard Rules for decades, and we've talked about Six Sigma for years. So what happens when we try to talk about both at the same time? Westgard Sigma Rules
Celebrate 15 years of evidence-based quality goals! The 8th update of the biologic variation database, with updated specifications and new analytes for 2014.
Small point-of-care chemistry analyzers continue to enter the market. Is the latest model an acceptable substitute for core lab quality results?
For all its ubiquity in the lab, proper QC isn't easy. Even though every laboratory has to perform Quality Control, that hasn't made the task any simpler. It still relies on the right mean, the right SD, the right control limits, the right rules and numbers of control measurements, and the right interpretation of control data points. If you get one part of this system wrong, it can throw off the correct implementation. Here's an example that was recently published showing the difficulties and challenges of performing proper QC.
An analysis of 4 different point-of-care (POC) analyzers and one POC device for HbA1c, based on a study published in 2012. The focus of the study was to find practical POC devices that could support faster decision making for the country's large HIV population. The question is, do any POC devices provide adequate quality for that type of clinical care?
With the expiration date on EQC drawing ever closer, US labs still await the details about its replacement. While CLSI EP23 has been public for more than a year, and CMS has made press releases about the new IQCP (Individualized Quality Control Plans) and has announced the benefits of this new forthcoming policy, the actual regulatory language has yet to be released or described.